Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
GLP-1 treatments may reduce knee replacement surgery rates
GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with…
Existing drug mitigates muscle loss from GLP-1 medications
Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along…
People judge GLP-1 users more harshly than dieters
Even as GLP-1 medications transform obesity treatment, new research reveals a surprising reality: people may face stigma whether…
Study finds GLP-1 medicines cut fat while preserving muscle function
A new study in mice and humans suggests GLP-1 medicines drive weight loss primarily by reducing fat, while…
Investigating microglia’s role in Alzheimer’s pathology
Announcing a new article publication for BIO Integration journal. Alzheimer’s disease (AD) is a neurodegenerative disorder and the…
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
UCLA Health finds eco-friendly inhalers improve COPD outcomes
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
Opioid receptor agonists take advantage of new understanding of GPCR biology
Opioid receptors are fantastic targets for treating pain—but unfortunately, the drugs that target them can be addictive.…
Study finds GLP-1 drugs improve strength and reverse aging biology in mice
New multi-omic data reveal that GLP-1 signaling in the brain can drive body-wide rejuvenation, offering a potential weight-neutral…